Search Contract Opportunities

Anthrax Antitoxin (monoclonal antibody)

ID: 75A50324C00006 • Type: Justification

Description

Justification and Approval relating to procurement of FDA-approved anthrax antitoxin (monoclonal antibody) is hereby published in accordance with FAR 6.305(a).

Overview

Award Date
April 30, 2024
Response Deadline
None
Posted
May 3, 2024, 10:57 a.m. EDT
Set Aside
None
Place of Performance
United States
Source
SAM

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Value Range
Experimental
$5,000,000 - $20,000,000 (AI estimate)
On 5/3/24 HHS Office of the Assistant Secretary for Preparedness and Response issued Justification 75A50324C00006 for Anthrax Antitoxin (monoclonal antibody).
Primary Contact
Name
Terri Reed   Profile
Phone
(202) 760-5886

Documents

Posted documents for Justification 75A50324C00006

Question & Answer

Contract Awards

Prime contracts awarded through Justification 75A50324C00006

Potential Bidders and Partners

Awardees that have won contracts similar to Justification 75A50324C00006

Similar Active Opportunities

Open contract opportunities similar to Justification 75A50324C00006

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR/ORM-SNS
FPDS Organization Code
7505-75A503
Source Organization Code
500175942
Last Updated
June 2, 2024
Last Updated By
terri.reed@hhs.gov
Archive Date
June 2, 2024